Announcements Trials
Browse Landscape

Status

Recruiting 3Active not recruiting 3Completed 2Withdrawn 1Terminated 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 1

Interventions

ulixertinib 1tebentafusp 1lifileucel 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × lifileucel × Dermatologic × Clear all
NCT05398640 2026-04-20

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Iovance Biotherapeutics, Inc.

Available
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡